bibliographicCitation |
Hu S, Fu W, Xu W, Yang Y, Cruz M, Berezov SD, Jorissen D, Takeda H, Zhu W. Four-in-one antibodies have superior cancer inhibitory activity against EGFR, HER2, HER3, and VEGF through disruption of HER/MET crosstalk. Cancer Res. 2015 Jan 01;75(1):159–70. doi: 10.1158/0008-5472.can-14-1670. PMID: 25371409. |